OpenAlex
PricingAboutJobs
Log inGet started
Work

TAX-TORC: A phase I trial of the combination of AZD2014 (dual mTORC1/mTORC2 inhibitor) and weekly paclitaxel in patients with solid tumors.

HTML

Year: 2014
Type: conference-abstract
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.2014.32.15_suppl.2607
Authors: Desamparados Roda, Han Hsi Wong, Elena Geuna, Saeed Rafii, Ruth Ruddle, Angela Hayes, Karen E Swales, Sarah Jane Stimpson, Nitharsan Sathiyayogan, Nina Tunariu, Alison Joanne Turner, Emma Hall, Timothy Anthony Yap, Susana N. Banerjee, Mary E.R. O'Brien, L Rhoda Molife, Stan B Kaye, Johann Sebastian De Bono, Bristi Basu, Udai Banerji
Institutions: Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Cambridge University Hospitals NHS Foundation Trust, Royal Marsden Hospital, Cancer Research UK
Language: English

Topic: PI3K/AKT/mTOR signaling in cancer
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2601980656
Cites:
Cited by: 2
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms